BioPharma & Healthcare Related News

CRISPR Therapeutics and Casebia Therapeutics Announce Exclusive Development and Option Agreement with StrideBio

BASEL, Switzerland and CAMBRIDGE, Mass. and DURHAM, N.C., April 17, 2017 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, and Casebia Therapeutics, a joint-venture established by CRISPR Therapeutics and Bayer [...]

By | April 18th, 2017|BioPharma & Healthcare, News, Press Releases, Therapeutics|

New Cloud-Based PerkinElmer Signals™ Notebook Helps Scientists Accelerate Drug Discovery Research

April 3, 2017 - WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the launch of the PerkinElmer Signals™ Notebook at the American Chemical Society (ACS) Spring National Meeting and Exposition Booth #619 PerkinElmer's [...]

By | April 4th, 2017|BioPharma & Healthcare, News, Press Releases|

Intrexon, ZIOPHARM and Merck KGaA, Darmstadt, Germany Advancing Next-Generation Non-Viral CAR-T Platform Empowered by Membrane-Bound IL-15 Under RheoSwitch Therapeutic System Control

Germantown, MD, and Boston, MA, April 3, 2017 - Intrexon Corporation (NYSE: XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, ZIOPHARM Oncology (NASDAQ: ZIOP), a biopharmaceutical company [...]

By | April 3rd, 2017|BioPharma & Healthcare, News, Press Releases, Therapeutics|

Oxitec’s Friendly™ Aedes Achieves 81% Suppression of Wild Aedes aegypti in CECAP/Eldorado, Piracicaba, in Second Year of Project

Piracicaba, March 30th, 2017 - Oxitec and Piracicaba City Hall announced today new results from the Friendly™ Aedes project in the CECAP/Eldorado district and the first results in the São Judas neighborhood in the city’s central region. In CECAP/Eldorado, Friendly™ [...]

By | April 2nd, 2017|BioPharma & Healthcare, Disease Prevention, News, Press Releases|

Cell Design Labs Announces Issuance of Broad Patent for Programmable Car-T Cells to Treat Cancer and Other Diseases

SAN FRANCISCO, Calif. – March 15, 2017 – Cell Design Labs, Inc. today announced the issuance of U.S. Patent No. 9,587,020, entitled, “Chimeric Antigen Receptor and Methods of Use Thereof.” This patent, issued to UC San Francisco (UCSF) and exclusively [...]

By | March 26th, 2017|BioPharma & Healthcare, News, Press Releases, Therapeutics|

eGenesis Co-Founder Luhan Yang Named Young Global Leader by World Economic Forum

Cambridge, Mass. – March 15, 2017 – Co-founder and chief scientific officer, Luhan Yang, Ph.D., has been honored as a Young Global Leader with the class of 2017. This honor is granted by the World Economic Forum each year to [...]

By | March 20th, 2017|BioPharma & Healthcare, News, Press Releases, Therapeutics|